AMRX compared with JXN: revenue, margins and what each company keeps, and the suppliers and customers both name

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

JXNJackson Financial Inc.

Mkt capRevenueRevenue

Compare

AMRXAmneal Pharmaceuticals, Inc.

JXNJackson Financial Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMRX 14

—Customer Aunlistedcustomer

—Kashiv Biosciencesunlistedsupplier

—ApiJect Systemsunlistedsupplier

—BIAL-Portela & Caunlistedsupplier

10 more · AMRX chain ›

Shared 0

No disclosed counterparties: JXN.

Only JXN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AMRXAmneal Pharmaceuticals, Inc.

20.44▼−4.98%· post 20.44· delayed

Mkt cap$6.9BRevenue$796MQ2 FY26Revenue$3.0BFY25

JXNJackson Financial Inc.

138.21▲+2.43%· post 138.07· delayed

After hoursNov 2 '26delayed

Mkt cap$9.1BRevenue$2.8BQ2 FY26Revenue$10.5BFY25

Compare

After hoursNov 2 '26delayed

AMRXAmneal Pharmaceuticals, Inc.

JXNJackson Financial Inc.

20.44▼−4.98%post 20.44delayed

Price

138.21▲+2.43%post 138.07delayed

$6.9B

Mkt cap

$9.1B

Q2 FY26$796M

Revenue

$2.8BQ2 FY26

FY25$3.0B

Revenue

$10.5BFY25

AMRX20.44▼−4.98%vsJXN138.21▲+2.43%After hoursNov 2 '26delayed